Home Ingredients E-TPGS (Water-Soluble Vitamin E)
Antioxidant

E-TPGS (Water-Soluble Vitamin E)

Evidence Level
Preliminary
0 Clinical Trials
3 Documented Benefits
1/5 Evidence Score

E-TPGS (d-alpha-tocopheryl polyethylene glycol succinate) is a water-soluble form of natural vitamin E. It serves both as a source of antioxidant vitamin E and as an absorption enhancer that improves the uptake of fat-soluble nutrients. Its main role is as a delivery form rather than a stand-alone studied supplement. The human evidence cited on this page comes from seven patients with ultra-rare inherited fat-malabsorption disorders. In that study the water-soluble form was better absorbed in one subgroup, but the two vitamin E formulations produced similar outcomes after four months. The other reference is pharmaceutical formulation science about drug delivery. No cited study looked at a healthy person taking E-TPGS as a supplement.

Studied Dose Per the product or formulation. No supplemental dose has been established for healthy people. The only human study cited used it as vitamin E replacement in patients with inherited fat-malabsorption disorders.
Active Compound d-alpha-tocopheryl polyethylene glycol 1000 succinate (water-soluble vitamin E).

Benefits

Vitamin E source

E-TPGS provides natural-source vitamin E (alpha-tocopherol) in a water-soluble form. Vitamin E is the body's main fat-soluble antioxidant, so the antioxidant classification on this page rests on what the molecule is, a vitamin E derivative. No study cited on this page measured antioxidant status in people taking E-TPGS.

Absorption enhancement

E-TPGS is used to improve the absorption of vitamin E and other fat-soluble compounds, and it is the vitamin E form used clinically when fat absorption is impaired, as in cholestasis, cystic fibrosis and rare inherited fat-malabsorption disorders. That is a real but narrow clinical use. The supporting evidence is pharmaceutical formulation research plus one crossover study in seven patients. In that study the water-soluble form reached higher bioavailability in the four patients with chylomicron retention disease, but after four months of treatment the two vitamin E formulations produced similar outcomes. Nothing cited here tests whether this absorption advantage does anything for a person who absorbs fat normally.

Delivery-form note

Its primary role is as a water-soluble delivery form and absorption enhancer rather than a separately studied health supplement. It normally appears as one component of a formula at an amount chosen by the formulator, and in the pharmaceutical literature the endpoint being measured is usually the delivery of the substance it carries rather than an effect of E-TPGS itself.

Mechanism of action

1

Antioxidant vitamin E activity

Once delivered, alpha-tocopherol protects cell membranes from lipid peroxidation as the body's main fat-soluble antioxidant. This is established vitamin E biochemistry rather than a result measured in a trial of E-TPGS.

2

Micelle-forming absorption

The polyethylene glycol portion makes vitamin E water-dispersible, forming micelles that improve uptake of fat-soluble nutrients.

Clinical trials

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated at normal vitamin E intakes. The safety concerns below attach to high-dose vitamin E, not to the small amounts used as a delivery aid.
Very high vitamin E doses can increase bleeding risk. Two further findings concern high-dose vitamin E generally, which is the family this ingredient belongs to. A meta-analysis of vitamin E supplementation trials linked doses of 400 IU per day or more with an increase in all-cause mortality. The large SELECT trial found a significant increase in prostate cancer incidence in healthy men taking 400 IU per day of vitamin E. Do not take high-dose vitamin E without medical advice.
Discontinue if any unusual reaction occurs.

Important Drug interactions

Anticoagulants (warfarin) — high-dose vitamin E may add to bleeding risk; monitor.
May enhance absorption of fat-soluble drugs; tell your doctor. TPGS is used in pharmaceuticals precisely because it raises drug absorption, partly by inhibiting the P-glycoprotein efflux pump, so it can raise blood levels of medicines taken alongside it. This matters most for drugs with a narrow safe dose range.
Stop high-dose vitamin E before surgery, per your doctor.

More Antioxidant Ingredients

Antioxidant
Green Tea
Green tea extract, derived from Camellia sinensis leaves, is rich in antioxidants like cat…
Antioxidant
Lutein
Lutein is a yellow carotenoid antioxidant that plays a key role in eye health, particularl…
Antioxidant
Vitamin E
Vitamin E is a family of fat-soluble antioxidants, the most active being alpha-tocopherol,…
Antioxidant
Selenium
Selenium is an essential trace mineral that the body uses to build antioxidant enzymes (su…

Explore Other Ingredients

Antioxidant
Alpha Lipoic Acid
Alpha-lipoic acid (ALA) is a versatile antioxidant made naturally in the body that is unus…
Antioxidant
Milk Thistle
Milk thistle, from the Silybum marianum plant, contains silymarin, a group of plant compou…
Antioxidant
NAC (N-Acetylcysteine)
NAC (N-Acetyl Cysteine) is a supplemental form of the amino acid cysteine, best known for…

Frequently asked questions about E-TPGS (Water-Soluble Vitamin E)

What is E-TPGS?

E-TPGS (d-alpha-tocopheryl polyethylene glycol succinate) is a water-soluble form of natural vitamin E. It serves both as a source of antioxidant vitamin E and as an absorption enhancer that improves the uptake of fat-soluble nutrients. Its main role is as a delivery form rather than a stand-alone studied supplement.

What is E-TPGS used for?

E-TPGS is researched primarily for Antioxidant. E-TPGS provides natural-source vitamin E (alpha-tocopherol) in a water-soluble form. Vitamin E is the body's main fat-soluble antioxidant, so the antioxidant classification on this page rests on what the molecule is, a vitamin E derivative.

What is the recommended dosage of E-TPGS?

The clinically studied dose is Per the product or formulation. No supplemental dose has been established for healthy people. The only human study cited used it as vitamin E replacement in patients with inherited fat-malabsorption disorders. Always follow the product label and check with a healthcare provider for personal advice.

Is E-TPGS safe, and does it have side effects?

For most healthy adults, E-TPGS is well tolerated at studied doses. Reported effects can include: Generally well-tolerated at normal vitamin E intakes. The safety concerns below attach to high-dose vitamin E, not to the small amounts used as a delivery aid. Very high vitamin E doses can increase bleeding risk. It may also interact with some medications. E-TPGS is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does E-TPGS interact with any medications?

Possible interactions include: Anticoagulants (warfarin) — high-dose vitamin E may add to bleeding risk; monitor. May enhance absorption of fat-soluble drugs; tell your doctor. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for E-TPGS?

NutraSmarts rates the evidence for E-TPGS as Preliminary (1 out of 5). It is backed by 2 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Guo Y, Luo J, Tan S, Otieno BO, Zhang Z The applications of Vitamin E TPGS in drug delivery European Journal of Pharmaceutical Sciences. 2013;49(2):175-186. doi:10.1016/j.ejps.2013.02.006.PubMedUsed to support: Review of pharmaceutical formulation science. It describes vitamin E TPGS as an excipient used to solubilize drugs, improve their absorption and inhibit the P-glycoprotein efflux pump involved in drug resistance. It supports the claim that TPGS enhances absorption of substances formulated with it. It is not a study of a health benefit in people, it reports no clinical outcome, and its subject is drug delivery rather than nutrient supplementation.
  2. Cuerq C, Henin E, Restier L, Blond E, Drai J, Marçais C, Di Filippo M, Laveille C, Michalski MC, Poinsot P, Caussy C, Sassolas A, Moulin P, Reboul E, Charriere S, Levy E, Lachaux A, Peretti N Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease Journal of Lipid Research. 2018;59(9):1640-1648. doi:10.1194/jlr.M085043.PubMedUsed to support: Crossover study in seven patients in total: three with abetalipoproteinemia and four with chylomicron retention disease, both extremely rare inherited recessive disorders of fat absorption. It compared tocofersolan, the water-soluble vitamin E form that is this page's molecule, against alpha-tocopherol acetate, using a single dose and then four months of treatment. Bioavailability was higher with the water-soluble form in the chylomicron retention disease patients, but the two formulations gave similar outcomes at four months. This is the entire human clinical evidence base for this ingredient. It involved neither healthy people nor any antioxidant endpoint.